Impact of the Covid-19 pandemic on WRMSDs
PREMUS, WDPI, & MYOPAIN 2023
Prevention of Musculoskeletal Disorders and Work Disability in the New Ways of Working
The Covid-19 pandemic has had a significant impact on workers with work-related musculoskeletal disorders (WRMSDs). WRMSDs are a group of disorders that affect the musculoskeletal system and are caused or aggravated by work-related activities. The most common WRMSDs include back pain, shoulder and neck pain, carpal tunnel syndrome, and repetitive strain injuries. The pandemic has caused a shift in the way many people work. With more people working from home, there has been an increase in the use of technology such as computers, laptops, and tablets. This has caused an increase in the number of people experiencing WRMSDs, as working on these devices for long periods of time can strain the musculoskeletal system. In addition, people are spending more time in the same position, such as sitting in front of a computer, which can lead to further strain on the body. Furthermore, people who are now working from home may not have access to the same ergonomic equipment they had in the office, such as adjustable chairs and desks, which can further increase the risk of developing WRMSDs. The pandemic has also caused an increase in stress and anxiety, both of which can exacerbate existing WRMSDs. Additionally, the lack of physical activity due to social distancing measures has caused a decrease in muscle strength and flexibility, which can increase the risk of developing WRMSDs. To help protect workers from developing WRMSDs, employers should provide ergonomic equipment, such as adjustable chairs, keyboards, and computer monitors, to employees who are working from home. Additionally, employers should provide guidance on how to set up an ergonomic workspace, including advice on how to adjust the chair, posture, and monitor height. Employers should also encourage employees to take regular breaks and maintain a healthy work-life balance. Finally, employers should ensure that their employees have access to mental health resources to help manage any stress or anxiety that may be contributing to their WRMSDs. The Covid-19 pandemic has also affected those who are already suffering from WRMSDs. Since many people are still working from home, they may not have the same level of access to medical services or treatments. For example, medical specialists may not be available or physical therapy may be limited. This can make it difficult for those with WRMSDs to manage their condition. To help those with WRMSDs manage their condition during the pandemic, employers should provide guidance on how to self-manage their condition. This can include advice on how to modify activities and make adjustments to the workspace to reduce strain or pain. In addition, employers should encourage employees to use available resources such as mental health services or online physical therapy. Finally, employers should ensure that employees have access to the necessary medical services should they need them.
ABOUT PREMUS, WDPI, & MYOPAIN 2023
11th PREMUS, 6th WDPI, & 11th MYOPAIN International Scientific Conference
on Prevention of Work-Related Musculoskeletal Disorders, Work Disability Prevention and Integration, and Myofascial Pain Syndrome & Fibromyalgia Syndrome; intending to transform healthcare with all the ground breaking innovations in the Prevention of MSDs and Disability Prevention and Integration, the PREMUS, WDPI, & MYOPAIN 2023 Conference is your only forum for exploring future research collaborations with over 500 global experts.?
PREMUS and WDPI are the international conferences of the Musculoskeletal Disorders (MSD) and Work Disability Prevention and Integration (WDPI) Scientific Committees of the International Commission of Occupational Health. MYOPAIN is the World Conference of the International Myopain Society.
MAIN OBJECTIVES
ORGANISER
CO-ORGANISERS
SUPPORTING ORGANISATIONS
ORGANIZING COMMITTEE
SCIENTIFIC COMMITTEE
Call for Abstracts is now open!
Recoup Health, host of PREMUS, WDPI, & MYOPAIN 2023 11th International Conference on Prevention of Work-Related Musculoskeletal Disorders (PREMUS), 6th International Conference on Work, Disability, Prevention & Integration (WDPI), 11th International Conference on Myofascial Pain Syndrome & Fibromyalgia Syndrome (MYOPAIN), invites you to showcase your work to your peers.?
PREMUS, WDPI, & MYOPAIN 2023 is taking place in Bengaluru, India and Online from September 20-26, 2023
Submitting an abstract gives you the opportunity to share your knowledge globally at the highest level. There would also be an opportunity to contribute to the textbook for medical professionals titled “Work-Related Musculoskeletal Disorders in the New Ways of Working: Pathophysiology, Diagnosis, Management, and Prevention” and a book for office workers titled “Understanding Work-Related Musculoskeletal Disorders in the New Ways of Working.” These books would be published after the PREMUS, WDPI, & MYOPAIN 2023 conference.?
Allow your research to gain some much-deserved visibility. Don’t miss the opportunity to promote your research to a wide audience of professional?peers globally.?
All the accepted abstracts and selected full papers will be allotted a DOI and published in the Indian Journal of Occupational and Environmental Medicine-IJOEM (ISSN-0973-2284), the official publication of the Indian Association of Occupational Health. This prestigious openaccess journal is Indexed in PubMed Central and does not require Article Processing Charges. IJOEM Journal
There are seven categories for submissions, these include:
IMPORTANT TIMELINES
Abstract Submission Deadline
MAR 31, 2023
Abstract Acceptance Notification
APR 30, 2023
Early Bird Registration Deadline
MAY 31, 2023
Deadline to Confirm Acceptance to Present
MAY 31, 2023
Pre-Conference Workshops
Sep 20-21, 2023
Main Conference
Sep 22-24, 2023
领英推荐
Post-Conference Workshops
Sep 25-26, 2023
THEME: “Prevention of Musculoskeletal Disorders and Work Disability in the New Ways of Working”
SUB-THEMES
PREMUS
WDPI
MYOPAIN
SUBMITTING AN ABSTRACT
? Once an abstract is submitted, the submitter will receive a confirmation email directly from the system ([email protected]) with an individual portal link associated with the “Edit Application Here” button within the email.?
? Submitters are asked to whitelist the domain pheedloop.com and/or mark [email protected] as a safe sender in their inbox to ensure delivery of any important communications. Please click this link for instructions on how to whitelist emails depending on your email provider.?
? If an abstract submission is incomplete and not submitted, the system will issue a reminder email with a link to access the submission in progress.?
? For the best user experience use Google Chrome. A note that the submission portal does not work on Internet Explorer.
REGARDING YOUR SUBMISSION:
? All abstracts must be submitted in English.?
? Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.?
? You will receive a confirmation via email after you have submitted your proposal.?
? All submissions must be completed through the online portal for PREMUS, WDPI, & MYOPAIN 2023 to accept the submissions.?
? Proposals submitted by email will not be accepted.?
? After the deadline, no changes will be accepted.?
? If you are unable to submit proposals via the website, please contact [email protected]?
? Abstracts should be submitted in a format ready for publication.?
? Please proofread to avoid any typographic or grammatical errors.?
? Authors should prepare their abstracts in advance using any standard word processing system, and then ‘copy and paste’ the elements from the word processing document into the appropriate spaces in the submission system.?
? Please do not include author names, references, acknowledgements, figures, images, or tables in your abstract body. There are separate sections for the author list and a figure/table for the abstract.?
? A figure/image/table is strongly recommended to be included for workshop, symposium submissions. Omission of a figure/image/table in these categories will lower the score of your abstract during the evaluation process.?
? Figures uploaded will not be published but will be reviewed during adjudication.?
? All submissions should include the first cycle results. Audits must be completed in time to present interventions and second cycle data at PREMUS, WDPI, & MYOPAIN 2023.?
? Work-in-progress is only acceptable for extremely innovative or interesting approaches.?
? During the submission process, authors must specify if the abstract was accepted elsewhere and include the date, location and event. This does not disqualify an abstract from being selected.?
? Abstracts of published research studies are ineligible for submission.?
? You can edit or delete your abstract online at any time before the abstract deadline. If you wish to withdraw your abstract after that date you must inform us in writing via email at [email protected].?
? The Scientific and Educational Competitions Judging Committee reserves the right to re-allocate abstracts submitted to incorrect categories and will notify the submitting author.?
? The PREMUS, WDPI, & MYOPAIN 2023 committee reserves the right to change the number of oral sessions, prizes and categories depending on number and strength of submitted abstracts.
IF YOU ARE ACCEPTED:
? If your abstract is accepted, but you are not selected to present an oral presentation, you will be offered a digital display opportunity.?
? Detailed notifications of acceptance and guidelines for presentation will be sent by email (date to be confirmed).?
? Presenting authors must be registered and are required to pay the applicable registration fee and all other expenses involved in attending PREMUS, WDPI, & MYOPAIN 2023.
SUBMIT YOUR ABSTRACT TODAY!
Business Specialist at Regalix
2 年Dr. Deepak Sharan Med Dr. Ravi Modali, MBBS (KEMH, Mumbai). Diplomate Lifestyle Medicine (IBLM, USA) It's encouraging to see that the conference is addressing this issue and providing a platform for discussion and solutions. I hope that this will lead to greater awareness and action to prevent and mitigate the impact of these disorders on our workforce.